000 01804 a2200481 4500
005 20250516091633.0
264 0 _c20121113
008 201211s 0 0 eng d
022 _a1873-2364
024 7 _a10.1016/j.nmd.2012.03.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohen, Tatiana V
245 0 0 _aMyogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.
_h[electronic resource]
260 _bNeuromuscular disorders : NMD
_cJul 2012
300 _a648-58 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aCalreticulin
_xgenetics
650 0 4 _aCells, Cultured
650 0 4 _aDysferlin
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHistocompatibility Antigens Class I
_xgenetics
650 0 4 _aMembrane Proteins
_xdeficiency
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Transgenic
650 0 4 _aMuscle Development
_xdrug effects
650 0 4 _aMuscle Proteins
_xgenetics
650 0 4 _aMuscle, Skeletal
_xcytology
650 0 4 _aMutation
_xgenetics
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aPentacyclic Triterpenes
650 0 4 _aSatellite Cells, Skeletal Muscle
_xdrug effects
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTime Factors
650 0 4 _aTranscription Factor RelA
_xgenetics
650 0 4 _aTriterpenes
_xpharmacology
700 1 _aCohen, Jonathan E
700 1 _aPartridge, Terence A
773 0 _tNeuromuscular disorders : NMD
_gvol. 22
_gno. 7
_gp. 648-58
856 4 0 _uhttps://doi.org/10.1016/j.nmd.2012.03.002
_zAvailable from publisher's website
999 _c21757229
_d21757229